5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Clinical trial NCT05850377 · UNKNOWN

Trial details

NCT number: NCT05850377
Sponsor: Sociedad de Lucha Contra el Cáncer del Ecuador
Status: UNKNOWN
Study type: OBSERVATIONAL

High Grade Glioma Glioma Glioma, Malignant Neoplasms, Neuroepithelial Neuroectodermal Tumors Photosensitizing Agents Neoplasm Malignant Brain Neoplasms, Adult, Malignant Central Nervous System Neoplasms Brain Tumor Tumour, Residual

Start date: 2023-06-01
Primary completion: 2026-05-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.